Multiplicom
Universiteit Antwerpen

Multiplicom

Biotech
Biotech
Biotech
Biotech

Acquired by Agilent Technologies

Multiplicom was created in 2011 as a spin-off of the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine.

Acquired by Agilent Technologies.

No items found.

This company is aligned with the following SDGs

No items found.
Axithra
Qbic III
HealthTech
HealthTech
HealthTech
HealthTech

Axithra

Axithra is developing new technology for accurate drug concentrations in blood

Universiteit Gent
imec
THERAtRAME
Qbic III
Biotech
Biotech
Biotech
Biotech

THERAtRAME

THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer

ULiège
Abscint
Qbic II
Biotech
Biotech
Biotech
Biotech

Abscint

Acquired by Curium

VUB
UZ Brussel